The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: infliximab     Quarter: 2016Q3

Total Records: 643     Number of Pages: 33

DRUGNAME PT EventCount
INFLIXIMAB HOSPIRA Tongue disorder 1
INFLIXIMAB HOSPIRA Urinary tract infection bacterial 1
INFLIXIMAB RECOMBINANT Alanine aminotransferase increased 1
INFLIXIMAB RECOMBINANT Antinuclear antibody positive 1
INFLIXIMAB RECOMBINANT Complement factor decreased 1
INFLIXIMAB RECOMBINANT Double stranded DNA antibody positive 1
INFLIXIMAB RECOMBINANT Drug effect incomplete 1
INFLIXIMAB RECOMBINANT Inappropriate schedule of drug administration 1
INFLIXIMAB RECOMBINANT Mobility decreased 1
INFLIXIMAB RECOMBINANT Rash 1
INFLIXIMAB RECOMBINANT Therapeutic response decreased 1
INFLIXIMAB, 100 MG VIAL JANSSEN Immunosuppression 1
INFLIXIMAB, 100 MG VIAL JANSSEN Meningitis listeria 1
INFLIXIMAB, RECOMBINANT Abdominal infection 1
INFLIXIMAB, RECOMBINANT Abortion induced 1
INFLIXIMAB, RECOMBINANT Abortion spontaneous 1
INFLIXIMAB, RECOMBINANT Acute myocardial infarction 1
INFLIXIMAB, RECOMBINANT Acute respiratory distress syndrome 1
INFLIXIMAB, RECOMBINANT Alopecia 1
INFLIXIMAB, RECOMBINANT Anal fistula 1

Total Records: 643     Number of Pages: 33